Participant eligibility
eating disorder, breast cancer
TYPE 1 DIABETES, TYPE 2 DIABETES, BREAST CANCER
We will recruit adult females (≥ 18 years) diagnosed with early-stage (I–III) breast cancer who will receive any type of neoadjuvant (pre-surgical) or adjuvant intravenous chemotherapy. Individuals without access to a cellphone with Bluetooth capability (required for intervention adherence tracking) will be excluded. We will exclude individuals who have type 1 diabetes and type 2 diabetes if hemoglobin A1c > 10 % or are taking insulin or sulfonylureas. For safety reasons, we will also exclude participants with research MRI contraindications (e.g. pacemaker, pregnancy, and magnetic implants), a self-reported history of an eating disorder, BMI < 18·5 kg/m